InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: dasgrunt post# 6199

Saturday, 01/07/2017 6:19:06 AM

Saturday, January 07, 2017 6:19:06 AM

Post# of 14871
Dasgrunt, according to Linkedin the position is in Irvine, California

Molecular Biologist

Interestingly Par Pharmaceuticals which was acquired by Endo for $8.05 Billion in 2015 has a presence in Irvine California.

Stephen P. Carey, Vice President and Chief Financial Officer hired in May 2016. Previously, Mr. Carey served as Senior Vice President, Controller and Principal Accounting Officer of Par Pharmaceutical Companies, Inc., a generic and specialty pharmaceutical company. During his tenure at Par, Mr. Carey supported the company through significant growth, multiple M&A transactions and a public to private equity transaction,

In addition, in Teva had been looking to sell their Irvine Plant by 2017 and have the buyer continue supplying Teva with product. I don't know if Teva still intends to sell the plant since they acquired Actavis Generics.

According to the jobs postings on Linkedin, this does seem like a company getting ready to sell.

Teva Irvine Jobs

Personally, the Molecular Biologist position will be forging a relationship with PAR (Endo) and strengthening their ANI's relationship with Teva.

JMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News